Cargando…
Repurposing antifungals: population pharmacokinetics of itraconazole and hydroxy-itraconazole following administration of a nanocrystal formulation
OBJECTIVES: To describe itraconazole and hydroxy-itraconazole pharmacokinetics following intravenous (IV) administration of a previously developed nanocrystal formulation (NCF) in haematopoietic cell transplant (HCT) recipients for prophylaxis of invasive fungal disease. METHODS: In a prospective Ph...
Autores principales: | Jansen, Anouk M E, Ter Heine, Rob, Donnelly, J P, Blijlevens, Nicole, Brüggemann, Roger J M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154123/ https://www.ncbi.nlm.nih.gov/pubmed/36935381 http://dx.doi.org/10.1093/jac/dkad072 |
Ejemplares similares
-
475. Does Metabolite Matter? Defining Target Itraconazole and Hydroxy-itraconazole Serum Levels for Blastomycosis
por: Hess, Danielle, et al.
Publicado: (2022) -
Production of Itraconazole Nanocrystal-Based Polymeric Film Formulations for Immediate Drug Release
por: Karagianni, Anna, et al.
Publicado: (2020) -
Pharmacokinetic and clinical comparison of super-bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis
por: Dhoot, Dhiraj, et al.
Publicado: (2023) -
Effect of Itraconazole on the Pharmacokinetics of Diclofenac in Beagle Dogs
por: Al-Jenoobi, Fahad I.
Publicado: (2010) -
Characteristics of Skin Deposition of Itraconazole Solubilized in Cream Formulation
por: Kim, Hyeongmin, et al.
Publicado: (2019)